Hoskins I A, Katz J, Frieden F J, Ordorica S A, Young B K
Department of Obstetrics and Gynecology, New York University Medical Center, NY 10016.
Am J Obstet Gynecol. 1990 Dec;163(6 Pt 1):1944-7. doi: 10.1016/0002-9378(90)90778-6.
Assessment of leukocyte esterase activity in amniotic fluid for the rapid and reliable diagnosis of chorioamnionitis has been demonstrated previously. We compared in vitro inhibition of esterase activity in amniotic fluid with bacterial cultures to identify the origins of the specific esterases released by the infecting organisms. One hundred forty-one samples were tested (90 uninfected, 51 infected). Each sample was evaluated for Gram stain, cultures, and an in vitro esterase assay followed by ebelactone inhibition. Forty-two patients had positive amniotic fluid cultures. Ebelactone produced varying degrees of inhibition of esterase activity (range, 20% to 60%) in the uninfected samples and in those infected with gram-negative organisms. There was no inhibition in the samples infected with gram-positive organisms. Thus different groups of bacteria may elicit the production of different and specific esterases in infected amniotic fluid, as shown by the differences in in vitro inhibition.
先前已证实,通过评估羊水白细胞酯酶活性可快速、可靠地诊断绒毛膜羊膜炎。我们将羊水酯酶活性的体外抑制与细菌培养进行比较,以确定感染生物体释放的特定酯酶的来源。共检测了141份样本(90份未感染,51份感染)。对每个样本进行革兰氏染色、培养以及体外酯酶测定,随后进行埃贝内酯抑制试验。42例患者羊水培养呈阳性。埃贝内酯在未感染样本和感染革兰氏阴性菌的样本中对酯酶活性产生了不同程度的抑制(范围为20%至60%)。感染革兰氏阳性菌的样本中未出现抑制现象。因此,如体外抑制差异所示,不同组别的细菌可能在感染的羊水中引发不同且特定酯酶的产生。